PS

Prema Singh Gaharwar

Active Director Director DIN 07800103
DIN 07800103 First appointment Apr 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2017
Shareholding value •••• Premium profile

About Prema Singh Gaharwar

Data last updated:

Prema Singh Gaharwar is a Director at Niyamba Pharmaceutical Private Limited (since 2017). The company operates in Pharma. Niyamba Pharmaceutical Private Limited reported revenue of ₹1.03 Cr (FY 2025).

DIN 07800103
Primary Designation Director
Industry Pharma
First Appointment 21 Apr 2017
Oldest Company Age 10 yrs
Largest company Niyamba Pharmaceutical Private Limited · ₹1.03 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Apr 20172016₹1.03 Cr (FY 2025)Active

Board colleagues of Prema Singh Gaharwar

Directorship timeline

Open interactive timeline →
Niyamba Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Prema Singh Gaharwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prema Singh Gaharwar

Prema Singh Gaharwar currently holds 1 directorship: Niyamba Pharmaceutical Private Limited (Director, since 21 Apr 2017, revenue ₹1.03 Cr (FY 2025)).

Prema Singh Gaharwar was first appointed on 21 Apr 2017 as Director at Niyamba Pharmaceutical Private Limited.

The current boards of Prema Singh Gaharwar's companies include Arti Soni (Niyamba Pharmaceutical Private Limited), Rahul Singh (Niyamba Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available